0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: ホーム > Recombinant Antibodies > Spike RBD > S1N-M164

Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (AM130) (MALS verified)

  • Source
    Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (AM130) is a chimeric monoclonal antibody combining the constant domains of the human IgA1 molecule with mouse variable regions.
  • Isotype
    Human IgA1/kappa
  • Specificity
    This product can recognize SARS-CoV-2 and SARS-CoV Spike Protein RBD domainn. No cross-reactivity is detected with Spike Protein RBD domain of other coronaviruses, including MERS-CoV, HCoV-229E, HCoV-NL63, HCoV-OC43 and HCoV-HKU1.
  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20 to -70°C for 12 months in lyophilized state from date of receipt;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (Cat. No. S1N-M164) SDS-PAGE gel

Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (Cat. No. ) MALS images

The purity of Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (Cat. No. S1N-M164) is more than 85% and the molecular weight of this protein is around 145-160 kDa verified by SEC-MALS.

Bioactivity-ELISA
Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (Cat. No. S1N-M164) ELISA bioactivity

Immobilized SARS-CoV-2 S protein RBD, His Tag (Cat. No. SPD-C52H1) at 2 μg/mL (100 μL/well) can bind Anti-SARS-CoV-2 Spike RBD Antibody, Chimeric mAb, Human IgA1 (AM130) (Cat. No. S1N-M164) with a linear range of 4-125 ng/mL (QC tested).

  • Background
    It's been reported that Coronavirus can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
  • Clinical and Translational Updates
      
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

コメント (0)

注文詳細

Price(USD) : $380.00

Price(USD) : $2500.00

プロモーション&展示



データシート&ドキュメンテーション

Request for DMF
DMF (Drug Master File)

連絡先

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

お問い合わせ&コメント

This web search service is supported by Google Inc.

totop